Las Vegas, NV -- (SBWIRE) -- 10/03/2013 -- PennyStockParlay.com Our process for picking penny stocks is not only unconventional, but untapped, undiscovered, and also exclusive. To keep our picks consistent with how only the "Best Penny Stocks" perform in the penny stock market, we have to keep our penny stock picks producing large and consistent gains.Have a look at today’s active stocks: Annaly Capital Mgmt (NYSE:NLY), Aeropostale, Inc., (NYSE;ARO) SED International Holdings (NYSE:SED), Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)
Annaly Capital Mgmt (NYSE:NLY) declares conversion rate adjustment for 4.00% Convertible Senior Notes due 2015.
Can Investors Bet on Annaly Capital Mgmt after this News update? Find out in this Research Report
The adjustment to the conversion rate for the Notes is being performed pursuant to the governing indenture for the Notes in light of the co's formerly declared third quarter 2013 common stock cash dividend of $0.35 per common share.
Aeropostale, Inc., (NYSE;ARO) is a mall-based, specialty retailer of casual apparel and accessories, principally targeting 14 to 17 year-old young women and men through its Aeropostale stores and 4 to 12 year-old kids through its P.S. from Aeropostale stores. P.S. from Aeropostale products can be purchased in P.S. from Aeropostale stores, in certain Aeropostale stores, and online at www.ps4u.com.
Can Investors Bet on Aeropostale after this News update? Find out in this Research Report
Aeropostale, Inc traded down on a volume of 200, inferior than its standard daily volume
SED International Holdings (NYSE:SED), Paragon files suit versus SED to hold annual meeting; re-issues warning to SED Board about entrenchment activities (SED). Paragon Technologies, Inc. has on Wednesday filed litigation versus SED International Holdings, Inc. (NYSE MKT:SED) in Gwinnett County, Georgia to compel SED to call and keep its 2013 annual meeting of shareholders, which SED is needed under its by-laws and applicable law to keep by the end of December 2013.
Can Investors Bet on SED International Holdings after this News update? Find out in this Research Report
Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
Will Keryx Biopharmaceuticals Continue To Move Higher? Find Out Here
Shares have gained 1.44% to $10.57. Over the last twelve months, the stock has lost-76.96% and faced a worst price of $0.20.HRT
Penny stocks are stocks that can be traded in the stock market at a very cheap price. The investor who decides to buy penny stocks should have a substantial intellect of the market and should be bequeathing to possibly suffer a loss in money. The phrase penny stock is usually used for stock dealing that does not imply the greater and popularly known exchanges.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the PennyStockParlay.comnewsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
PennyStockParlay.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your investment manager before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies in the profiled on the PennyStockParlay.com web site and/or newsletter involve a high degree of risk and volatility, and all investors should know that they may lose a portion or all of their investment if they decide to purchase any stock.
Read Full Disclaimer at: http://pennystockparlay.com/disclaimer.html
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)